Kronos Advanced Technologies, Inc. (OTC: KNOS) Reports Fiscal 2025 Revenue Achievement

LOS ANGELES, CA — January 20, 2026 — Kronos Advanced Technologies, Inc. (OTC: KNOS), a diversified technology and wellness company, today announced that its controlled subsidiary, Zyppah, Inc., generated approximately $2.21 million in revenue for the fiscal year ended October 31, 2025 based on unaudited internal financial results. This milestone highlights continued commercial traction in consumer health and digital wellness markets.

Zyppah: Core Driver of Fiscal 2025 Revenue Growth

Zyppah, Inc. is a direct-to-consumer sleep wellness company specializing in patented, FDA-cleared snoring and sleep-related products sold through e-commerce channels such as Amazon and Shopify. The company’s portfolio includes custom comfort devices, mouthpiece solutions, nasal strips, and other accessories targeting sleep health improvement.

Since its founding, Zyppah has achieved significant cumulative sales, surpassing $55 million in total products sold and serving more than 500,000 customers globally. The brand has also developed a proprietary customer database and fulfillment structure that management believes sets it apart from early-stage wellness brands.

Executive Insights: Strategic Value and Future Growth

Greg Rubin, CEO of Kronos Advanced Technologies, emphasized the importance of Zyppah’s performance in fiscal 2025, stating that the results reflect Zyppah’s established marketplace presence and strategic fit within Kronos’ broader technology portfolio. According to Rubin, the company is well positioned to expand its reach in the digital health and wellness space — a trend that continues to attract consumer demand and investor interest.

Rubin also commented on the synergies between Kronos’ technology vision and Zyppah’s consumer business model, noting that integrating wellness products with next-generation digital health technologies may unlock additional opportunities for growth and innovation.

Foundational History and Brand Recognition

Zyppah was founded by Dr. Jonathan Greenburg, a dentist and inventor recognized for expertise in oral appliance-based sleep solutions. Dr. Greenburg is credited with developing Zyppah’s patented “Seat Belt for the Tongue” technology, which combines tongue stabilization and mandibular advancement to reduce airway obstruction during sleep.

Over the years, Zyppah and its products have received national media exposure, including appearances on major TV and digital platforms that have helped build brand awareness. Dr. Greenburg reiterated that the fiscal 2025 results highlight the ongoing demand for clinically proven sleep health solutions, and he expressed optimism about leveraging Kronos’ technological capabilities to reach new customer segments worldwide.

KronosMD and Integration with Advanced Digital Health Tools

In addition to Zyppah, Kronos Advanced Technologies owns KronosMD, Inc., a subsidiary focused on advanced oral health technologies. KronosMD is developing SWAVE™, an innovative, radiation-free intraoral ultrasound imaging platform intended to support remote oral scanning and data capture.

Company leadership believes that SWAVE™ technology could complement Zyppah’s product ecosystem by enabling remote digital impressions for customers seeking custom oral appliance solutions — potentially reducing dependency on traditional in-office workflows. However, no assurances regarding timing, regulatory approval, or commercial implementation of such technology have been provided.

Financial Reporting Context and Disclosure

The revenue figures disclosed for Zyppah represent standalone operating results for the period ending October 31, 2025 and are unaudited. Kronos noted that these results reflect internal management financial statements and are not consolidated under U.S. Generally Accepted Accounting Principles (GAAP). The figures remain subject to final adjustments following year-end closing procedures.

Management emphasized that Zyppah’s performance adds a revenue-generating consumer wellness platform to Kronos’ broader technology portfolio, supported by established intellectual property and a substantial customer base.

About Zyppah, Inc.

Zyppah Inc. is a consumer health company dedicated to developing FDA-cleared, patented solutions aimed at reducing snoring and improving sleep quality by addressing underlying physiological causes of sleep disruptions. The company’s offerings include the ZYPPAH® Pro mouthpiece, Special Edition products, and related accessories designed through a “boil-and-bite” fitting process for personalized comfort.

Backed by published clinical research and a high success rate in reducing snoring in study participants, Zyppah’s products are marketed worldwide and supported by brand visibility from media features and notable partnerships.

About Kronos Advanced Technologies, Inc.

Kronos Advanced Technologies, Inc. is a technology company focused on innovative solutions across health, wellness, and environmental domains. Founded in 2002 and initially funded by U.S. military programs, Kronos has evolved into a diversified enterprise with core competencies in air purification, digital health technologies, and energy solutions.

The company’s portfolio includes medical-grade air purification technologies with FDA clearance, digital dental diagnostic innovations, and consumer health platforms operated through its subsidiaries. Kronos aims to integrate digital health and advanced diagnostics with consumer-oriented product offerings to drive long-term stakeholder value.

Forward-Looking Considerations

As with many technology and wellness companies operating in dynamic markets, Kronos Advanced Technologies cautions that forward-looking statements regarding future performance, technology development, regulatory pathways, and commercial outcomes are subject to risks and uncertainties that could cause actual results to differ materially. Investors and stakeholders are encouraged to review publicly disclosed financial filings and company updates for ongoing developments.